Hancock Lowporosity Valved Conduit
PMA P870078
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP870078 | Date28 Sep 1989 | StatusActive |
Recalls
-
- Terminated Z-2623-2014
Medtronic has decided to discontinue production and distribution of this low-volume product.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade Name
- Hancock Porcine Bioprosthesis
- Generic Name
- replacement Heart-valve
- PMA Number
- FDA Product Code
- DYE
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3925
- Advisory Committee
- Cardiovascular
- FDA Decision
- APPR Approved
Overview
AI-generated summary, 18 Sep 2026
The Hancock Lowporosity Valved Conduit is a replacement heart-valve device designed for cardiovascular applications. It is manufactured by Medtronic, Inc. and identified by the trade name Hancock Porcine Bioprosthesis.
This device is supplied as a valved conduit and has received FDA Premarket Approval (PMA) under number P870078. It is classified as a Class III medical device and is intended for use in cardiovascular procedures as indicated by its regulatory classification and advisory committee assignment.
Other devices from Medtronic, Inc.
Questions
AI-generated answers, 18 Sep 2026
What type of device is the Hancock Lowporosity Valved Conduit?
The Hancock Lowporosity Valved Conduit is a replacement heart-valve device, as defined by its generic name and FDA classification under regulation number 870.3925 for cardiovascular use.
Who manufactures the Hancock Lowporosity Valved Conduit and where are they located?
The device is manufactured by Medtronic, Inc., located at 1851 E. Deere Ave., Santa Ana, CA 92705, as specified in the device data.
What regulatory authorization does the Hancock Lowporosity Valved Conduit have?
The device has FDA Premarket Approval (PMA) authorization, with PMA number P870078, and was approved on September 28, 1989, following receipt of the application on December 8, 1987.